![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Lynch Donna-Marie
Publisher: Adis International
ISSN: 1173-2563
Source: Clinical Drug Investigation, Vol.27, Iss.9, 2007-01, pp. : 661-662
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Epoetin alfa improves QOL in cancer-related anaemia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 251, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Epoetin alfa cost effective in breast cancer with anaemia
Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Epoetin alfa improves QOL in cancer-related anaemia
Inpharma, Vol. 1, Iss. 1228, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Epoetin alfa: improved QOL for patients with anaemia and RA
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :